Paris - Delayed Quote EUR

DBV Technologies S.A. (DBV.PA)

2.0850
+0.1410
+(7.25%)
As of 9:22:24 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
114,648
116,590
76,433
96,631
99,535
Operating Income
-114,648
-116,590
-76,433
-96,631
-99,535
Net Non Operating Interest Income Expense
1,004
2,726
3,714
427
425
Other Income Expense
--
--
--
--
920
Pretax Income
-113,645
-113,863
-72,719
-96,204
-98,189
Tax Provision
7
55
7
70
-381
Net Income Common Stockholders
-113,652
-113,918
-72,726
-96,274
-97,809
Diluted NI Available to Com Stockholders
-113,652
-113,918
-72,726
-96,274
-97,809
Basic EPS
-1.15
-1.17
-0.76
-1.24
-1.78
Diluted EPS
-1.15
-1.17
-0.76
-1.24
-1.78
Basic Average Shares
98,605.7220
97,350.4270
95,121.3900
77,661.2900
54,948.8760
Diluted Average Shares
98,605.7220
97,350.4270
95,121.3900
77,661.2900
54,948.8760
Total Operating Income as Reported
-114,649
-116,589
-76,432
-96,631
-98,614
Total Expenses
114,648
116,590
76,433
96,631
99,535
Net Income from Continuing & Discontinued Operation
-113,652
-113,918
-72,726
-96,274
-97,809
Normalized Income
-113,652
-113,918
-72,726
-96,274
-98,725.4120
Net Interest Income
1,004
2,726
3,714
427
425
EBIT
-114,648
-116,590
-76,433
-96,631
-99,535
EBITDA
-107,891
-109,045
-67,272
-83,469
-86,316
Reconciled Depreciation
-26
-925
-13,998
13,162
8,376
Net Income from Continuing Operation Net Minority Interest
-113,652
-113,918
-72,726
-96,274
-97,809
Total Unusual Items Excluding Goodwill
--
--
--
0
920
Total Unusual Items
--
--
--
0
920
Normalized EBITDA
-107,891
-109,045
-67,272
-83,469
-87,236
Tax Rate for Calcs
0.0004
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
3.5880
12/31/2021 - 3/29/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PHXM.PA PHAXIAM Therapeutics S.A.
0.3510
-1.13%
 
GNFT.PA Genfit S.A.
3.7800
-1.61%
 
OSE.PA OSE Immunotherapeutics SA
6.03
-0.90%
 
NANO.PA Nanobiotix S.A.
3.3950
+0.89%
 
ALTHX.PA Theranexus Société Anonyme
0.6614
0.00%
 
VLA.PA Valneva SE
2.8920
-0.21%
 
POXEL.PA Poxel S.A.
0.4290
+6.45%
 
IPH.PA Innate Pharma S.A.
1.9760
-0.70%
 
GNRO.PA GeNeuro SA
0.0690
0.00%
 
CYAD.BR Celyad Oncology SA
0.4500
0.00%